P. Allavena

P. Allavena, M. Broggini, M. D’Incalci, 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Effects of granulocyte‐monocyte colony‐stimulating factor (GM‐CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer‐associated macrophages

P. Allavena, A. Mantovani, S. Bernasconi, 1995, International journal of cancer.

Chemokines and Dendritic Cell Traffic

P. Allavena, A. Mantovani, S. Sozzani, 2000, Journal of Clinical Immunology.

Chemokine Receptor Expression and Function in CD4+ T Lymphocytes with Regulatory Activity1

P. Allavena, C. Albanesi, G. Girolomoni, 2001, The Journal of Immunology.

Human glioma tumors express high levels of the chemokine receptor CX3CR1.

P. Allavena, A. Mantovani, S. Pesce, 2010, European cytokine network.

Chemokine and Receptor Expression in Tumor Progression

P. Allavena, A. Mantovani, F. Marchesi, 2007 .

Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

P. Allavena, A. Mantovani, A. Stoppacciaro, 2001, The Journal of clinical investigation.

Fractalkine ( CX 3 CL 1 ) as an amplification circuit of polarized Th 1 responses

P. Allavena, A. Mantovani, A. Stoppacciaro, 2001 .

c‐fos proto‐oncogene expression in human NK/LGL cells: Expression is not constitutive and is associated with functional activation

P. Allavena, A. Mantovani, F. Colotta, 1988, International journal of cancer.

In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma

P. Allavena, A. Mantovani, S. Bernasconi, 2005, Cancer Immunology, Immunotherapy.

Human large granular lymphocytes are potent producers of interleukin-1

P. Allavena, J. Ortaldo, J. Djeu, 1984, Nature.

Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients.

S. Topino, S. Uccini, P. Allavena, 1997, The American journal of pathology.

The systemic capillary leak syndrome: appearance of interleukin-2-receptor-positive cells during attacks.

A. Rosti, P. Allavena, M. Cicardi, 1990, Annals of internal medicine.

Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapy

P. Allavena, M. D’Incalci, M. Liguori, 2021, European journal of immunology.

Control of dendritic cell migration by chemokines.

P. Allavena, A. Mantovani, S. Sozzani, 1999, Forum.

The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.

P. Allavena, L. Piemonti, C. Pasquali, 2003, Cancer research.

Differential Effects of Immunosuppressive Drugs on Chemokine Receptor CCR7 in Human Monocyte-Derived Dendritic Cells: Selective Upregulation by Rapamycin

P. Allavena, A. Mantovani, W. Luini, 2006, Transplantation.

Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium

P. Allavena, A. Mantovani, E. Dejana, 1991, The Journal of experimental medicine.

Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets.

E. Bonifacio, P. Allavena, F. Bertuzzi, 2005, Blood.

Macrophages as tools and targets in cancer therapy

P. Allavena, C. Garlanda, A. Mantovani, 2022, Nature Reviews Drug Discovery.

IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF.

P. Allavena, A. Mantovani, S. Bernasconi, 1995, European cytokine network.

Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.

P. Allavena, A. Mantovani, C. Mangioni, 1981, Journal of the National Cancer Institute.

The Inflammatory Milieu of Tumors: Cytokines and Chemokines that Affect Tumor Growth and Metastasis

L. Wakefield, P. Allavena, A. Sica, 2018 .

Intraperitoneal administration of corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: Effects on cytotoxicity of tumor‐associated macrophages and NK cells

P. Allavena, A. Mantovani, C. Sessa, 1981, International journal of cancer.

Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines.

M. Gobbi, P. Allavena, A. Mantovani, 1997, Journal of immunology.

Intestinal Epithelial Cells Control Dendritic Cell Function

P. Allavena, M. Rescigno, M. Vulcano, 2004, Annals of the New York Academy of Sciences.

Chemokines as targets for pharmacological intervention.

P. Allavena, A. Mantovani, P. Proost, 1996, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

Commitment of juvenile myelo-monocytic (JMML) leukemic cells to spontaneously differentiate into dendritic cells.

P. Allavena, S. Bernasconi, C. Niemeyer, 2002, The hematology journal : the official journal of the European Haematology Association.

The good and the bad side of Heme-oxygenase-1 in the gut.

P. Allavena, G. Marelli, 2019, Antioxidants & redox signaling.

Regulatory Activity T Lymphocytes with + Function in CD4 Chemokine Receptor Expression and

P. Allavena, C. Albanesi, G. Girolomoni, 2000 .

Regulation of the chemokine system at the level of chemokine receptor expression and signaling activity.

P. Allavena, A. Mantovani, S. Sozzani, 2001, Immunobiology.

Shaping and tuning of the chemokine system by regulation of receptor expression and signaling: dendritic cells as a paradigm

P. Allavena, S. Sozzani, M. Locati, 2000, Journal of Neuroimmunology.

Adhesion, transendothelial migration, and reverse transmigration of in vitro cultured dendritic cells.

P. Allavena, A. Mantovani, S. Bernasconi, 1998, Blood.

Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells

P. Allavena, A. Mantovani, S. Bernasconi, 1998, International journal of clinical & laboratory research.

Cytokine Activation of Endothelial Cells: New Molecules for an Old Paradigm

P. Allavena, A. Mantovani, S. Sozzani, 1997, Thrombosis and Haemostasis.

Induction of natural-killer-cell migration by monocyte chemotactic protein-1, protein-2 and protein-3

P. Allavena, A. Mantovani, Dan Zhou, 1994 .

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma

C. Hurt, P. Allavena, A. Mantovani, 2021, npj Precision Oncology.

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity

P. Allavena, A. Mantovani, Clément Anfray, 2021, Journal for ImmunoTherapy of Cancer.

Therapeutic Manipulation of Tumor-associated Macrophages: Facts and Hopes from a Clinical and Translational Perspective

P. Allavena, Clément Anfray, A. Ummarino, 2021, Clinical Cancer Research.

Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment

P. Allavena, M. D’Incalci, R. Frapolli, 2022, Frontiers in Oncology.

Molecules Involved in the Recruitment and Regulation of Tumor-Associated Macrophages

P. Allavena, A. Mantovani, S. Sozzani, 1998 .

Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin‐2 activated killer cells and by activated monocytes

P. Allavena, A. Mantovani, M. D’Incalci, 1987, International Journal of Cancer.

Lymphocytes of a patient with lymphoproliferative disease of large granular lymphocytes express high natural killer, ADCC, and LAK activity.

P. Allavena, M. Passeri, P. Sansoni, 1990, Clinical immunology and immunopathology.

Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells

P. Allavena, G. Tagliabue, M. D’Incalci, 2005, Cancer Immunology, Immunotherapy.

Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104)

P. Allavena, C. Galmarini, M. D’Incalci, 2013, International journal of cancer.

Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.

P. Allavena, A. Mantovani, A. Lissoni, 1990, Cancer research.

MAGE, BAGE and GAGE genes experiences in fresh epithelial ovarian carcinomas

P. Allavena, P. Dalerba, C. Bordignon, 1996 .

MAGE BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas.

P. Allavena, P. Dalerba, C. Bordignon, 1996, International journal of cancer.

T cell receptor (alpha, beta, gamma) gene rearrangements and expression in normal and leukemic large granular lymphocytes/natural killer cells.

T. Barbui, P. Allavena, A. Mantovani, 1987, Blood.

Immunological and genotypic analysis of human Tγ-lymphoproliferative disorders

T. Barbui, P. Allavena, A. Mantovani, 1986, La Ricerca in Clinica e in Laboratorio.

Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor.

P. Allavena, A. Mantovani, J. Wang, 1987, Immunology.

Myelokathexis associated with multiple congenital malformations: Immunological study on phagocytic cells and lymphocytes

P. Allavena, A. Plebani, G. Collo, 1988, European journal of haematology.

Dendritic Cells Leukocytes: Selective Expression of TLR3 in Toll-Like Receptors (TLR) in Human Differential Expression and Regulation of

P. Allavena, A. Mantovani, A. Stoppacciaro, 2000 .

Truncation of Macrophage-derived Chemokine by CD26/ Dipeptidyl-Peptidase IV beyond Its Predicted Cleavage Site Affects Chemotactic Activity and CC Chemokine Receptor 4 Interaction*

P. Allavena, G. Opdenakker, P. Proost, 1999, The Journal of Biological Chemistry.

to pancreatic islets functionally active chemokine receptors capable of promoting migration Bone marrow mesenchymal stem cells express a restricted set of

E. Bonifacio, P. Allavena, F. Bertuzzi, 2013 .

Chemokines: Attraction of dendritic cells and role in tumor immunobiology

P. Allavena, A. Mantovani, S. Sozzani, 1998 .

Rapamycin impairs antigen uptake of human dendritic cells1

P. Allavena, L. Piemonti, D. Valerio, 2003, Transplantation.

Autoimmunity and b‐cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cells

T. Barbui, P. Allavena, A. Mantovani, 1989, Cancer.

Chemokines and Chemokine Receptors

P. Allavena, C. Garlanda, A. Mantovani, 1999 .

Regulation of chemokine receptor expression in dendritic cells.

P. Allavena, A. Mantovani, S. Sozzani, 1998, Research in Immunology.

Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses

P. Allavena, A. Mantovani, S. Sozzani, 1998, International journal of clinical & laboratory research.

The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.

P. Allavena, A. Mantovani, M. Reni, 2008, Cancer research.

Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)/CCL20 and MIP-3beta/CCL19.

P. Allavena, A. Mantovani, S. Sozzani, 2001, European journal of immunology.

Investigation of chronic lymphocytosis in adults.

T. Barbui, P. Allavena, A. Rambaldi, 1988, American Journal of Clinical Pathology.

Monocyte-Derived Dendritic Cells Maturation , and Function of Human Affects Differentiation , 3 Vitamin

P. Allavena, M. Sironi, L. Piemonti, 2000 .

Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer

P. Allavena, M. A. Kamal, S. Schiarea, 2022, Cancers.

Tumor-Associated Macrophages and Dendritic Cells as Prototypic Type II Polarized Myeloid Populations

P. Allavena, A. Sica, A. Mantovani, 2003, Tumori.

Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein‐1 and related chemokines

P. Allavena, A. Mantovani, S. Sozzani, 1995, Journal of leukocyte biology.

IL-4 inhibits binding and cytotoxicity of NK cells to vascular endothelium.

P. Allavena, A. Mantovani, C. Matteucci, 1994, Cytokine.

Production of multiple cytokines by clones of human large granular lymphocytes

P. Allavena, J. Ortaldo, J. Djeu, 2004, Cancer Immunology, Immunotherapy.

Lymphokine Production in Ty Lymphoproliferative Disorders

T. Barbui, P. Allavena, A. Mantovani, 1986 .

Induction of cytotoxicity by interleukin‐2 in tγ‐lymphoproliferative disorders

T. Barbui, P. Allavena, A. Villa, 1986 .

The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumour Metastatic Dissemination

P. Allavena, M. Erreni, 2017 .

Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Short title: Mesenchymal stem cells migrate to chemokines

E. Bonifacio, P. Allavena, L. Piemonti, 2005 .

Mesothelial cells induce the motility of human ovarian carcinoma cells

P. Allavena, G. Taraboletti, R. Giavazzi, 1999, International journal of cancer.

IL‐15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium

P. Allavena, A. Mantovani, G. Bianchi, 1997, Journal of leukocyte biology.

Expression of lineage‐restricted protein tyrosine kinase genes in human natural killer cells

R. Perlmutter, P. Allavena, A. Mantovani, 1991, European journal of immunology.

Activated adherent large granular lymphocytes/natural killer (LGL/NK) cells change their migratory behaviour.

P. Allavena, A. Mantovani, A. Pirelli, 1988, Immunology.

Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).

P. Allavena, J. Ortaldo, A. Procopio, 1985, Journal of immunology.

Subsets of human large granular lymphocytes (LGL) exhibit accessory cell functions.

P. Allavena, J. Ortaldo, R. Herberman, 1985, Journal of Immunology.

In vitro migration of human large granular lymphocytes.

P. Allavena, A. Mantovani, A. Villa, 1985, Journal of immunology.

Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ.

P. Allavena, A. Mantovani, A. Villa, 1983, Journal of the National Cancer Institute.

Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists

P. Allavena, Clément Anfray, A. Ummarino, 2022, Biomedicines.

COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)

P. Allavena, N. Normanno, G. Sozzi, 2021, ESMO Open.

Glucocorticoids increase the endocytic activity of human dendritic cells.

P. Allavena, L. Piemonti, V. Di Carlo, 1999, International immunology.

H1 variant synthesis in proliferating and quiescent human cells.

P. Allavena, M. D’Incalci, W. Bonner, 1986, European journal of biochemistry.

Characteristics of human NK clones: target specificity and phenotype.

P. Allavena, J. Ortaldo, 1984, Journal of immunology.

Differential responsiveness to constitutive versus inflammatory chemokines of immature and mature mouse dendritic cells

P. Allavena, A. Mantovani, S. Bernasconi, 1999 .

Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery *

P. Allavena, A. Mantovani, A. Ghidini, 2007, BJOG : an international journal of obstetrics and gynaecology.

IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences.

P. Allavena, A. Mantovani, S. Sozzani, 1997, Journal of immunology.

In Vitro Studies on the Trafficking of Dendritic Cells Through Endothelial Cells and Extra-Cellular Matrix

P. Allavena, S. Sozzani, G. D'Amico, 2000, Developmental immunology.

Induction of Functional IL-8 Receptors by IL-4 and IL-13 in Human Monocytes1

P. Allavena, A. Mantovani, S. Sozzani, 2000, The Journal of Immunology.

Regulation of adhesion and transendothelial migration of natural killer cells.

P. Allavena, A. Mantovani, G. Bianchi, 1996, Natural immunity.

Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

P. Allavena, A. Mantovani, S. Sozzani, 1998, The Journal of experimental medicine.

Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study

C. Bosetti, P. Allavena, G. Ceresoli, 2022, International journal of molecular sciences.

Ovarian Carcinoma Macrophages Associated with Human Chemotactic Protein-1 Receptor CCR 2 in Defective Expression of the Monocyte

P. Allavena, A. Sica, A. Mantovani, 1999 .

Human Macrophage–derived Chemokine (mdc), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells

P. Allavena, A. Mantovani, S. Sozzani, 1997 .

Transendothelial migration and reverse transmigration of in vitro cultured human dendritic cells.

P. Allavena, A. Mantovani, S. Sozzani, 2001, Methods in molecular medicine.

Chemotaxis of in vitro cultured human dendritic cells.

P. Allavena, A. Mantovani, S. Bernasconi, 2001, Methods in molecular medicine.

Old and new chemokines. Pharmacological regulation of chemokine production and receptor expression: mini-review.

P. Allavena, A. Mantovani, S. Bernasconi, 1998, Journal of chemotherapy.

Lymphokine-activated killer (LAK) and monocyte-mediated cytotoxicity on tumor cell lines resistant to antitumor agents.

P. Allavena, A. Mantovani, M. D’Incalci, 1989, Cellular immunology.

Killing of tumor cells with pleiotropic drug resistance by OK432-activated effector cells.

P. Allavena, A. Mantovani, F. Peccatori, 1989, Immunopharmacology and immunotoxicology.

Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells.

P. Allavena, L. Piemonti, V. Di Carlo, 2003, International immunopharmacology.

Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages

P. Allavena, Clément Anfray, A. Ummarino, 2022, Drug Delivery and Translational Research.

Role of leukocyte function-associated antigen-1 and very late antigen-4 in the adhesion and transmigration of c-myc-transfected B-lymphoblastoid cell lines across vascular endothelium

P. Allavena, R. Dalla Favera, G. Bianchi, 1994, International journal of clinical & laboratory research.

Clinical relevance of clonal hematopoiesis in the oldest-old population.

C. Peano, G. Castellani, S. Rosso, 2021, Blood.

T cell receptor beta chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells

T. Barbui, P. Allavena, A. Mantovani, 1985, The Journal of experimental medicine.

T-cell receptor gene rearrangements and expression in normal human large granular lymphocytes (LGL) and their pathological expansions

P. Allavena, A. Mantovani, F. Peccatori, 1987, Cytotechnology.

Association of large granular lymphocyte/natural killer cell proliferative disease and second hematologic malignancy

T. Barbui, P. Allavena, M. Abbate, 1988, American journal of hematology.

RAEB IN PATIENT WITH CHRONIC GRANULATED T‐LYMPHOCYTOSIS

T. Barbui, P. Allavena, R. Bassan, 1987, British journal of haematology.

IL-10 prevents the generation of dendritic cells from CD14+ blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran.

P. Allavena, A. Mantovani, S. Bernasconi, 1997, Advances in experimental medicine and biology.

Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy

P. Allavena, A. Mantovani, N. Colombo, 1992, International journal of cancer.

Patterns of T cell receptor gamma gene rearrangement and expression in B and T lymphoid malignancies.

P. Allavena, A. Neri, D. Littman, 1988, Leukemia.

Identification and genomic organization of a gene coding for a new member of the cell adhesion molecule family mapping to Xq25.

P. Allavena, P. Vezzoni, A. Frattini, 1998, Gene.

Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism

P. Allavena, M. Borrello, M. Erreni, 2019, Journal of experimental & clinical cancer research : CR.

Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues.

P. Allavena, A. Mantovani, G. Peri, 1983, Blood.

A randomized clinical trial to compare the efficacy of continuous local anesthetic wound infusion with thoracic epidural analgesia in post-operative pain control after pancreatic surgery

P. Allavena, P. Zito, S. Pesce, 2019 .

Role of tumor-associated macrophages in tumor progression and invasion

P. Allavena, A. Sica, A. Mantovani, 2006, Cancer and Metastasis Reviews.

The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.

P. Allavena, A. Sica, A. Mantovani, 2008, Critical reviews in oncology/hematology.

Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy

Federica Palorini, Barbara Avuzzi, Paola Allavena, 2018, Disease markers.

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.

Manuela Gariboldi, Angela Greco, Alberto Mantovani, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Trabectedin, a drug acting on both cancer cells and the tumour microenvironment

P. Allavena, C. Galmarini, M. D’Incalci, 2014, British Journal of Cancer.

IL‐10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages

P. Allavena, A. Stoppacciaro, L. Piemonti, 1998, European journal of immunology.

Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys

P. Allavena, A. Mantovani, P. Transidico, 2000, Nature Immunology.

Regulation of Inflammatory Cytokine Receptor Expression by Pro- and Anti-Inflammatory Molecules

S. Saccani, P. Allavena, A. Sica, 1998 .

CHAPTER 15 – Dendritic cells and chemokines

Silvano Sozzani, Alberto Mantovani, Paola Allavena, 2001 .

The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues

P. Allavena, A. Sica, S. Sozzani, 2000, Immunological reviews.

Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells

P. Allavena, M. Parmentier, L. Massimiliano, 1999, Journal of leukocyte biology.

Chemokines and chemokine receptors in the regulation of dendritic cell trafficking.

P. Allavena, A. Mantovani, S. Sozzani, 1999, Chemical immunology.

The role of chemokines in the regulation of dendritic cell trafficking

P. Allavena, S. Sozzani, A. Vecchi, 1999, Journal of leukocyte biology.

Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines.

P. Allavena, A. Mantovani, F. Sallusto, 1995, Journal of immunology.

Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4

P. Allavena, A. Mantovani, L. Piemonti, 2004, Cancer Research.

Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines.

M Locati, P. Allavena, A. Mantovani, 2001, Trends in immunology.

Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis.

P. Allavena, A. Mantovani, L. Piemonti, 2010, Cytokine & growth factor reviews.

Hepatocyte Growth Factor (HGF) Stimulates Tumor Cells to Release Chemokines Active in Recruiting Dendritic Cells

P. Allavena, A. Mantovani, M. Stella, 2000 .

Linking inflammation reactions to cancer: novel targets for therapeutic strategies.

P. Allavena, A. Sica, A. Mantovani, 2008, Advances in experimental medicine and biology.

Defective Expression of the Monocyte Chemotactic Protein-1 Receptor CCR2 in Macrophages Associated with Human Ovarian Carcinoma1

P. Allavena, A. Sica, A. Saccani, 2000, The Journal of Immunology.

P. Allavena, A. Sica, A. Mantovani, 2008, Cancer letters.

The Yin Yang of Cancer Related Inflammation

P. Allavena, C. Garlanda, A. Sica, 2011 .

Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma*

P. Allavena, A. Mantovani, G. Opdenakker, 2002, The Journal of Biological Chemistry.

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.

Alberto Mantovani, Paola Allavena, P. Allavena, 2006, European journal of cancer.

Tumor-associated macrophages and anti-tumor therapies: complex links

P. Allavena, M. D’Incalci, R. Frapolli, 2016, Cellular and Molecular Life Sciences.

Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells

P. Allavena, M. Rescigno, G. Viale, 2005, Nature Immunology.

Cytokines as a key component of cancer-related inflammation.

Alberto Mantovani, Paola Allavena, Giovanni Germano, 2008, Cytokine.

Tumor-associated myeloid cells: diversity and therapeutic targeting

P. Allavena, C. Garlanda, A. Mantovani, 2021, Cellular & Molecular Immunology.

Tumor-associated macrophages: functional diversity, clinical significance, and open questions

P. Allavena, A. Mantovani, S. Biswas, 2013, Seminars in Immunopathology.

Tumor-associated macrophages: functional diversity, clinical significance, and open questions

P. Allavena, A. Mantovani, S. Biswas, 2013, Seminars in Immunopathology.

Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer

P. Allavena, G. Caprara, M. Erreni, 2020, International journal of molecular sciences.

The presence of functional mannose receptor on macrophages at the maternal-fetal interface.

P. Allavena, A. Mantovani, V. S. Tokmadžić, 2005, Human reproduction.

NATURAL CYTOTOXICITY ON TUMOR CELLS OF HUMAN MONOCYTES AND MACROPHAGES1

P. Allavena, A. Mantovani, G. Peri, 1980 .

The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance

P. Allavena, C. Garlanda, A. Sica, 2008, Immunological reviews.

Macrophage polarization in pathology

P. Allavena, A. Sica, M. Erreni, 2015, Cellular and Molecular Life Sciences.

Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy

P. Allavena, A. Mantovani, F. Grizzi, 2015, Gut.

Mechanisms of natural cell-mediated resistance in human solid tumors.

P. Allavena, A. Mantovani, M. D. Di Bello, 1986, Biochimica et biophysica acta.

Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells

P. Allavena, A. Mantovani, A. Lissoni, 2004, Cancer Immunology, Immunotherapy.

Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors

P. Allavena, A. Mantovani, C. Sessa, 1980, International journal of cancer.

FUNCTIONAL STATUS OF TUMOR-ASSOCIATED EFFECTOR CELLS

P. Allavena, A. Mantovani, C. Bordignon, 1982 .

Cytotoxicity on tumor cells of human macrophages: functional status of tumor-associated effector cells.

P. Allavena, A. Mantovani, C. Bordignon, 1982, Advances in experimental medicine and biology.

Molecular pathways in cancer-related inflammation.

P. Allavena, A. Mantovani, M. Corsi, 2011, Biochemia medica.

Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.

P. Allavena, C. Garlanda, A. Sica, 2009, Human immunology.

Tumor-associated macrophages and anti-tumor therapies: complex links

P. Allavena, M. D’Incalci, R. Frapolli, 2016, Cellular and Molecular Life Sciences.

Tumor-associated macrophages, multi-tasking cells in the cancer landscape

P. Allavena, M. Erreni, G. Marelli, 2015 .

Tumor-Associated Macrophages

P. Allavena, A. Sica, Laura Straus, 2014 .

The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans.

Katia Perruccio, Francesco Bistoni, Richard A Calderone, 2004, International immunology.

Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines.

P. Allavena, A. Mantovani, S. Sozzani, 2000, Pharmaceutica acta Helvetiae.

The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant.

P. Allavena, A. Mantovani, G. Bernardini, 1998, Blood.

Interleukin-17–Producing T-Helper Cells as New Potential Player Mediating Graft-Versus-Host Disease in Patients Undergoing Allogeneic Stem-Cell Transplantation

G. Lucchini, P. Allavena, E. Berti, 2009, Transplantation.

Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients

P. Allavena, C. Garlanda, A. Mantovani, 2016, International journal of cancer.

The interaction of anticancer therapies with tumor-associated macrophages

P. Allavena, A. Mantovani, A. Mantovani, 2015, The Journal of experimental medicine.

Immunology in the clinic review series; focus on cancer: tumour‐associated macrophages: undisputed stars of the inflammatory tumour microenvironment

P. Allavena, A. Mantovani, A. Mantovani, 2012, Clinical and experimental immunology.

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

P. Allavena, A. Mantovani, F. Grosso, 2010, Cancer research.

Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation.

P. Allavena, A. Sica, A. Secchi, 2002, Diabetes.

Macrophage polarization in tumour progression.

P. Allavena, A. Sica, A. Mantovani, 2008, Seminars in cancer biology.

Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks

P. Allavena, R. Giavazzi, F. Carraro, 2011, Thrombosis and Haemostasis.

Inflammatory and Innate Immune Cells in Cancer Microenvironment and Progression

P. Allavena, A. Mantovani, P. Brennecke, 2015 .

Tumor-Associated Myeloid Cells in Cancer Progression

P. Allavena, A. Mantovani, M. Sironi, 2020, Cancer Immunology.

Inflammation and cancer: breast cancer as a prototype.

Alberto Mantovani, Paola Allavena, P. Allavena, 2007, Breast.

Chapter 27 – Tumor-associated Macrophages in Cancer Growth and Progression

P. Allavena, A. Sica, A. Mantovani, 2013 .

Tumor-Associated Macrophages in Cancer Growth and Progression

P. Allavena, A. Sica, A. Mantovani, 2007 .

Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers

P. Allavena, A. Mantovani, F. Grizzi, 2014, Clinical Cancer Research.

The Role of Chemokines and their Receptors in Tumor Progression and Invasion: Potential New Targets of Biological Therapy

P. Allavena, A. Mantovani, F. Marchesi, 2005 .

Tumors as a Paradigm for the In Vivo Role of Chemokines in Leukocyte Recruitment

P. Allavena, A. Sica, A. Mantovani, 1999 .

Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma

Fabio Grizzi, Francesco Novelli, Paola Allavena, 2016, Oncoimmunology.

Migration of natural killer cells across endothelial cell monolayers.

P. Allavena, A. Mantovani, M. Elices, 1993, Journal of immunology.

Microenvironment and Immunology of the Human Pleural Malignant Mesothelioma

P. Allavena, A. Mantovani, E. Digifico, 2019, Mesothelioma.

FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis

P. Allavena, A. Scarpa, B. Rusev, 2017, Oncogene.

DR antigen expression on ovarian carcinoma cells does not correlate with their capacity to elicit an autologous proliferative response

P. Allavena, A. Mantovani, N. Colombo, 2004, Cancer Immunology, Immunotherapy.

Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium.

P. Allavena, A. Mantovani, S. Sozzani, 1994, Blood.

Cells with stemness features are generated from in vitro transformed human fibroblasts

P. Allavena, P. Ostano, C. Mondello, 2018, Scientific Reports.

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment

P. Allavena, C. Galmarini, M. D’Incalci, 2014, Marine drugs.

Targeting tumour-associated macrophages

P. Allavena, A. Sica, A. Mantovani, 2007, Expert opinion on therapeutic targets.

Stimulation of cytotoxic and non-cytotoxic functions of natural killer cells by bacterial membrane proteoglycans and ribosomes.

P. Allavena, A. Mantovani, A. Pirelli, 1989, International journal of immunopharmacology.

A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile

P. Allavena, M. Reni, L. Piemonti, 2004, Virchows Archiv.

Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells

P. Allavena, A. Mantovani, A. Stoppacciaro, 2000 .

Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530

P. Allavena, A. Sica, A. Santoro, 2018, Clinical Cancer Research.

Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3

P. Allavena, A. Mantovani, Dan Zhou, 1994, European journal of immunology.

The chemokine system in cancer biology and therapy.

P. Allavena, A. Mantovani, L. Zammataro, 2010, Cytokine & growth factor reviews.

Soluble stroma‐related biomarkers of pancreatic cancer

V. Torri, P. Allavena, A. Scarpa, 2018, EMBO molecular medicine.

Macrophages and cancer stem cells: a malevolent alliance

P. Allavena, E. Digifico, C. Belgiovine, 2021, Molecular Medicine.

Chemokines in cancer related inflammation.

P. Allavena, A. Mantovani, G. Germano, 2011, Experimental Cell Research.

Cellular and molecular pathways linking inflammation and cancer.

P. Allavena, A. Sica, A. Mantovani, 2009, Immunobiology.

Targeting of the innate immunity/inflammation as complementary anti-tumor therapies

P. Allavena, A. Mantovani, G. Germano, 2011, Annals of medicine.

Original article: Natural killer (NK) and lymphokine activated killer (LAK) cell activity in patients (PTS) treated with favone acetic acid (FAA)

P. Allavena, R. Talamini, D. Crivellari, 1991 .

Pharmacological modulation of monocytes and macrophages.

P. Allavena, A. Mantovani, A. Vecchi, 2014, Current opinion in pharmacology.

FAM 49 B , a novel regulator of mitochondrial function and integrity that 1 suppresses tumour metastasis 2 3

P. Allavena, A. Scarpa, B. Rusev, 2022 .

Tumor-Associated Macrophages as Incessant Builders and Destroyers of the Cancer Stroma

P. Allavena, A. Mantovani, G. Solinas, 2011, Cancers.

Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells1

P. Allavena, A. Mantovani, A. Stoppacciaro, 2000, The Journal of Immunology.

Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T-Cells in Cancer Immunotherapy

P. Allavena, A. Mantovani, I. Siddiqui, 2020, Cancer Immunology.

Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition

P. Allavena, A. Mantovani, M. A. Kamal, 2018, Oncoimmunology.

Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer

P. Allavena, S. Pesce, M. Carvello, 2016, PloS one.

Molecular links between inflammation and cancer

P. Allavena, A. Mantovani, G. Germano, 2015 .

Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis

P. Allavena, A. Mantovani, M. Roncalli, 2013, British Journal of Cancer.

Functions of Diverse Myeloid Cells in the Tumor Micro-Environment

P. Allavena, A. Sica, 2012 .

Engagement of the Mannose Receptor by Tumoral Mucins Activates an Immune Suppressive Phenotype in Human Tumor-Associated Macrophages

P. Allavena, A. Mantovani, G. Solinas, 2011, Clinical & developmental immunology.

Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1.

P. Allavena, A. Mantovani, R. Draghi, 2010, European journal of cancer.

Inflammation-mediated promotion of invasion and metastasis

P. Allavena, C. Garlanda, A. Mantovani, 2010, Cancer and Metastasis Reviews.

Molecular pathways and targets in cancer-related inflammation

P. Allavena, C. Garlanda, A. Mantovani, 2010, Annals of medicine.

CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

V. Torri, P. Allavena, A. Mantovani, 2009, The Lancet. Oncology.

Expression of chemokines and chemokine receptors in human colon cancer.

P. Allavena, A. Mantovani, M. Locati, 2009, Methods in enzymology.

Monocytes from Wiskott‐Aldrich patients differentiate in functional mature dendritic cells with a defect in CD83 expression

L. Notarangelo, R. Badolato, S. Giliani, 2001, European journal of immunology.

The chemokine superfamily: crosstalk with the IL-1 system.

P. Allavena, A. Mantovani, S. Sozzani, 1996, Immunobiology.

Chemokines: a superfamily of chemotactic cytokines

P. Allavena, A. Mantovani, S. Sozzani, 1996, International journal of clinical & laboratory research.

Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression.

P. Allavena, A. Sica, A. Mantovani, 2004, European journal of cancer.

Macrophage polarization in pathology

P. Allavena, A. Sica, M. Erreni, 2015, Cellular and Molecular Life Sciences.

Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells1

P. Allavena, M. Sironi, L. Piemonti, 2000, The Journal of Immunology.

Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma

M. Zucchetti, P. Allavena, M. Reni, 2016, Cancer Chemotherapy and Pharmacology.

Interleukin‐1 and tumor necrosis factor production in acute non‐lymphoid leukemia

P. Allavena, A. Mantovani, F. Colotta, 1989, European journal of haematology.

PLGA Based Nanoparticles for the Monocyte-Mediated Anti-Tumor Drug Delivery System.

P. Allavena, M. Sironi, B. La Ferla, 2020, Journal of biomedical nanotechnology.

Targeting tumor associated macrophages: The new challenge for nanomedicine.

P. Allavena, A. Mantovani, M. Alonso, 2017, Seminars in immunology.

In vitro susceptibility of different human T‐cell subpopulations and resistance of large granular lymphocytes to HTLV‐I infection

P. Allavena, E. Bonmassar, J. Ortaldo, 1987, International journal of cancer.

2 Functions of Diverse Myeloid Cells in the Tumor MicroEnvironment

P. Allavena, A. Sica, M. Erreni, 2017 .

Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells

Alberto Mantovani, Andrea Doni, Paola Allavena, 2003, European journal of immunology.

Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1+ Cells

P. Allavena, A. Mantovani, M. Roncalli, 2020, Cancer Immunology Research.

Distinct Transcriptional Programs Activated by Interleukin-10 with or without Lipopolysaccharide in Dendritic Cells: Induction of the B Cell-Activating Chemokine, CXC Chemokine Ligand 131

Silvano Sozzani, Alberto Mantovani, Paola Allavena, 2004, The Journal of Immunology.

Monocyte–macrophage polarization and recruitment pathways in the tumour microenvironment of B‐cell acute lymphoblastic leukaemia

P. Allavena, C. Garlanda, A. Mantovani, 2021, British journal of haematology.

Tumor-Derived MUC1 Mucins Interact with Differentiating Monocytes and Induce IL-10highIL-12low Regulatory Dendritic Cell1

P. Allavena, L. Piemonti, V. Sordi, 2004, The Journal of Immunology.

Regulatory Dendritic CelllowIL-12 high Differentiating Monocytes and Induce IL-10 Tumor-Derived MUC 1 Mucins Interact with and

Marina, P. Allavena, L. Piemonti, 2004 .

Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program 1

P. Allavena, A. Mantovani, M. Sironi, 2003, The Journal of Immunology.

Cloned lines of SJL/J spleen cells with cytotoxic reactivity

P. Allavena, C. Riccardi, J. Ortaldo, 1983, International journal of cancer.

Gene Rearrangements and Expression in Normal and Leukemic Large Granular Lymphocytes / Natural Killer Cells

T. Barbui, P. Allavena, A. Mantovani, 2005 .

Inhibition of natural killer activity by human bronchoalveolar macrophages.

P. Allavena, A. Mantovani, C. Bordignon, 1982, Journal of immunology.

Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.

P. Allavena, A. Mantovani, C. Sessa, 1982, Journal of the National Cancer Institute.

CULTURE OF NK CELLS: SPECIFICITY, PHENOTYPES, FUNCTIONS AND COMPARISON WITH ACTIVATED T CELLS

P. Allavena, J. Ortaldo, R. Herberman, 1985 .

Isolation of human monocyte chemotactic proteins and study of their producer and responder cells by immunotests and bioassays.

P. Allavena, A. Mantovani, G. Opdenakker, 1997, Methods in Enzymology.

Specificity and phenotype of IL-2 expanded clones of human large granular lymphocytes.

P. Allavena, J. Ortaldo, 1983, Diagnostic immunology.

Soluble intercellular adhesion molecule-1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts.

P. Allavena, S. Bernasconi, M. Nicoletti, 1994, European journal of cancer.

Poly(I:C) stimulation is superior than Imiquimod to induce the antitumoral functional profile of tumor‐conditioned macrophages

P. Allavena, A. Mantovani, F. T. Andón, 2019, European journal of immunology.

Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype

P. Allavena, M. D’Incalci, S. Cutrupi, 2018, Oncoimmunology.

Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms

M. Cazzola, P. Allavena, C. Galmarini, 2017, British Journal of Cancer.

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models

M. Hidalgo, P. Allavena, R. Mangues, 2016, Disease Models & Mechanisms.

T cell receptor delta gene organization and expression in normal and leukemic natural killer cells.

M. Minden, T. Mak, T. Barbui, 1989, Journal of immunology.

NATURAL KILLER ACTIVITY IN HUMAN OVARIAN TUMORS

P. Allavena, A. Mantovani, N. Colombo, 1982 .

Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers.

P. Allavena, A. Mantovani, P. Sansonetti, 2008, Vaccine.

Vasodilation in multistep paradigm of leucocyte extravasation

P. Allavena, A. Mantovani, F. Colotta, 1994, The Lancet.

Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery

P. Allavena, M. Alloisio, A. Santoro, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Tumor-associated macrophages (TAMs) as new target in anticancer therapy

P. Allavena, A. Sica, A. Mantovani, 2006 .

malignant tissues possible mechanism contributing to blood clotting activation within Generation of procoagulant activity by mononuclear phagocytes: a

P. Allavena, A. Mantovani, G. Peri, 2011 .

Transcriptional Regulation of the Human TLR9 Gene1

Silvano Sozzani, Alberto Mantovani, Filippo Rossi, 2004, Journal of Immunology.

Human monocyte‐derived and CD34+ cell‐derived dendritic cells express functional receptors for platelet activating factor

P. Allavena, A. Mantovani, S. Sozzani, 1997, FEBS letters.

Distinct Transcriptional Programs Activated by Interleukin-10 with or without Lipopolysaccharide in Dendritic Cells: Induction of the B Cell-Activating Chemokine, CXC Chemokine Ligand 13.

Silvano Sozzani, Alberto Mantovani, Paola Allavena, 2004, The Journal of Immunology.

Cytokine regulation of tumour-associated macrophages.

P. Allavena, A. Mantovani, F. Colotta, 1993, Research in immunology.

Cellular and molecular pathways linking inflammation and cancer. Immunobiology

P. Allavena, A. Sica, A. Mantovani, 2009 .

Clinical Relevance of Clonal Hematopoiesis in the Oldest-Old Population

C. Peano, G. Castellani, S. Rosso, 2020, SSRN Electronic Journal.

MODULATION OF NK ACTIVITY BY HUMAN MONONUCLEAR PHAGOCYTES: SUPPRESSIVE ACTIVITY OF BRONCHO-ALVEOLAR MACROPHAGES

P. Allavena, A. Mantovani, C. Bordignon, 1982 .

Cytokine regulation of monocyte recruitment.

P. Allavena, A. Mantovani, F. Colotta, 1995, Archivum immunologiae et therapiae experimentalis.

New activities for the anti-tumor agent trabectedin: taking two birds with one stone

P. Allavena, M. D’Incalci, R. Frapolli, 2013, Oncotarget.

Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.

P. Allavena, A. Mantovani, C. Mangioni, 1986, Journal of the National Cancer Institute.

Lymphocytes infiltrating ovarian carcinoma: modulation of functional activity by intraperitoneal treatment with biological response modifiers.

P. Allavena, A. Mantovani, G. Peri, 1988, Natural immunity and cell growth regulation.

Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer

P. Allavena, S. Pesce, M. Carvello, 2016, PLoS ONE.

Tumor-associated Macrophages: Cytokine Regulation and Therapeutic Implications

P. Allavena, C. Garlanda, A. Mantovani, 1993 .

Biological Significance and Therapeutic Potential of Tumor-Associated Leukocytes

P. Allavena, A. Mantovani, F. Colotta, 1993 .

Cytokine Regulation of Tumor-Associated Macrophages: Therapeutic Implications

P. Allavena, C. Garlanda, A. Mantovani, 1993 .

Chemotaxis and interaction with vascular or lymphatic endothelium.

P. Allavena, A. Mantovani, S. Sozzani, 2004, Methods in molecular biology.

Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting

P. Allavena, C. Garlanda, A. Mantovani, 2023, Theranostics.

Macrophage control of inflammation: negative pathways of regulation of inflammatory cytokines.

P. Allavena, A. Mantovani, S. Sozzani, 2001, Novartis Foundation symposium.

Leukocyte transmigration through vascular endothelium. An in vitro method.

P. Allavena, A. del Maschio, 1999, Methods in molecular biology.

Leukocyte Transmigration Through Vascular Endothelium

P. Allavena, A. Maschio, 1999 .

Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma

C. Recordati, P. Allavena, M. Roncalli, 2023, Frontiers in immunology.

Non-redundant role of the chemokine receptor CX3CR1 in the anti-inflammatory function of gut macrophages.

P. Allavena, A. Mantovani, M. Erreni, 2017, Immunobiology.

How CX3CR1 + Macrophages Regulate Gut Homeostasis

P. Allavena, G. Marelli, 2017 .

Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium

P. Allavena, A. Mantovani, E. Dejana, 1991, The Journal of experimental medicine.

Trabectedin

P. Allavena, A. Mantovani, M. D’Incalci, 2013, Reactions Weekly.

Cells with stemness features are generated from in vitro transformed human fibroblasts

P. Allavena, P. Ostano, C. Mondello, 2018, Scientific Reports.

Abstract 1284: Lurbinectedin reduces tumor-associated macrophages and the production of inflammatory cytokines, chemokines, and angiogenic factors in preclinical models

P. Allavena, C. Galmarini, M. D’Incalci, 2016 .

T cell receptor beta chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells

T. Barbui, P. Allavena, A. Mantovani, 1985, The Journal of experimental medicine.

Inflammation and cancer: From bench to bedside?

P. Allavena, A. Sica, A. Mantovani, 2007 .

Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

P. Allavena, A. Mantovani, S. Sozzani, 1998, The Journal of experimental medicine.

Heme-oxygenase-1 Production by Intestinal CX3CR1+ Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis.

P. Allavena, A. Mantovani, S. Guglielmetti, 2017, Cancer research.

Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells

P. Allavena, A. Mantovani, S. Sozzani, 1997, The Journal of experimental medicine.

The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance

P. Allavena, C. Garlanda, A. Sica, 2008, Immunological reviews.

Targeting tumor associated macrophages: The new challenge for nanomedicine.

P. Allavena, A. Mantovani, M. Alonso, 2017, Seminars in immunology.

Molecular pathways and targets in cancer-related inflammation

P. Allavena, C. Garlanda, A. Mantovani, 2010, Annals of medicine.

P. Allavena, C. Garlanda, A. Sica, 2009, Carcinogenesis.

Immunohistohemical expression of the chemokine fractalkine and its receptor in the human brain cortex after severe traumatic brain injury and brain hemorrhage.

P. Allavena, G. Solinas, P. Gaetani, 2013, Journal of Neurosurgical Sciences.

CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

V. Torri, P. Allavena, A. Mantovani, 2009, The Lancet. Oncology.

Pathways connecting inflammation and cancer.

P. Allavena, C. Garlanda, M. Borrello, 2008, Current opinion in genetics & development.

Cytokine regulation of endothelial cell function.

P. Allavena, A. Mantovani, E. Dejana, 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

This information is current as IL-4 and IL-13 in Human Monocytes Induction of Functional IL-8 Receptors by

P. Allavena, A. Mantovani, S. Bernasconi, 2000 .

Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers.

P. Allavena, A. Mantovani, P. Sansonetti, 2008, Vaccine.

Role of PTX3 in pancreatic cancer

P. Allavena, H. Kocher, J. Watt, 2014, The Lancet.

Immunology in the clinic review series; focus on cancer: tumour‐associated macrophages: undisputed stars of the inflammatory tumour microenvironment

P. Allavena, A. Mantovani, 2012, Clinical and experimental immunology.

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models

M. Hidalgo, P. Allavena, R. Mangues, 2016, Disease Models & Mechanisms.

Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing

P. Allavena, S. Schiarea, F. Pasqualini, 2017 .

Chemokines in cancer related inflammation.

P. Allavena, G. Germano, F. Marchesi, 2011, Experimental cell research.

Induction of cytotoxicity by interleukin-2 in T gamma-lymphoproliferative disorders.

T. Barbui, P. Allavena, A. Villa, 1986, International journal of cancer.

Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells.

P. Allavena, S. Scarpino, Francesca Ballerini, 2000, American Journal of Pathology.

This information is current as Dendritic Cells Leukocytes : Selective Expression of TLR 3 in Toll-Like Receptors ( TLR ) in Human Differential Expression and Regulation of

P. Allavena, A. Stoppacciaro, D. Bosisio, 2000 .

Decidual natural killer cell tuning by autologous dendritic cells.

P. Allavena, H. Haller, D. Rukavina, 2008, American Journal of Reproductive Immunology.

In Vivo Analysis of Tumor-Associated Macrophages in the Tumor Microenvironment.

P. Allavena, Clément Anfray, A. Ummarino, 2023, Methods in molecular biology.